Julia Robinson is our clinical and science editor/
- [email protected]
The NHS is facing “considerable challenges” in supplying enough aseptically prepared injectable medicines, and chief pharmacists are responsible for ensuring adequate contingency plans are put in place.
As healthcare professionals prepare for blockbuster biologic Humira to come off patent on 16 October 2018, we highlight what pharmacists need to know about switching from originator biologics to biosimilars in order to get the best value from these medicines.
Monoclonal antibodies could significantly improve quality of life for individuals with severe asthma and reduce the need for oral corticosteroids and their side effects, a leading asthma charity has said.
Recent blog posts
Catch up on this year’s most read clinical trial stories, many of which cover important research into adverse effects of commonly used drugs.
Julia Robinson reports from a meeting discussing the implications of Brexit on UK pharmacovigilance.
The Royal Jizak has had a busy and challenging year. Julia Robinson describes the most popular ‘Your RPS’ articles of 2016.